Barclay Phillips Net Worth & Insider Trades

Barclay Phillips - SVP, Novavax Inc

As of August 1, 2017

What is Barclay Phillips's Net Worth?

The current estimated net worth of Novavax Inc's SVP, Barclay Phillips, is estimated to be about $8.42M . Barclay Phillips owns about 38,669 units of Novavax Inc common stock. In the last 4 years at Novavax Inc, Barclay Phillips has sold an estimated value of $395.55K worth.

What is Barclay Phillips's Past Insider Trading?

Barclay Phillips's largest purchase order was 50,000 units , worth over $95K on July 3, 2013. Barclay Phillips's largest sale order was 28,656 units , worth over $374.32K on August 21, 2015. In total, Barclay Phillips has made about 16 transactions over 4 years of their time at Novavax Inc. Barclay Phillips usually trades in August, with the busiest year in 2014, 2016 and 2015. The most recent transaction was a purchase order of 2,057 units , worth over $1.83K on August 1, 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Barclay Phillips's' Mailing Address?

  • Mailing address is C/o Cancer Vax Corp 2110 Rutherford Road Carlsbad CA 92008 CA

Novavax Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Stanley C. Erck Stanley C. Erck 2020 $657,181 $48,086,018 $44,115,244 $48,086,018 $11,400 $48,086,018
Stanley C. Erck Stanley C. Erck 2019 $642,720 $2,438,562 $986,660 $2,438,562 $11,200 $2,438,562
Stanley C. Erck Stanley C. Erck 2018 $638,040 $4,158,398 $3,509,358 $4,158,398 $11,000 $4,158,398
Gregory F. Covino 2020 $55,000 $1,417,774 $659,967 $1,417,774 $8,032 $1,417,774
Gregory F. Covino 2019 $― $― $― $― $― $―
Gregory F. Covino 2018 $― $― $― $― $― $―
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2020 $483,443 $24,923,376 $22,859,741 $24,923,376 $11,400 $24,923,376
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2019 $470,453 $1,875,198 $819,421 $1,875,198 $11,200 $1,875,198
Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. 2018 $460,125 $1,681,456 $1,131,189 $1,681,456 $11,000 $1,681,456
John J. Trizzino John J. Trizzino 2020 $415,892 $21,327,954 $19,819,717 $21,327,954 $11,400 $21,327,954
John J. Trizzino John J. Trizzino 2019 $390,701 $1,465,602 $584,103 $1,465,602 $9,546 $1,465,602
John J. Trizzino John J. Trizzino 2018 $378,078 $1,329,776 $890,700 $1,329,776 $7,500 $1,329,776
John A. Herrmann III John A. Herrmann III 2020 $402,842 $20,606,814 $18,924,907 $20,606,814 $11,400 $20,606,814
John A. Herrmann III John A. Herrmann III 2019 $378,591 $1,353,416 $488,397 $1,353,416 $11,200 $1,353,416
John A. Herrmann III John A. Herrmann III 2018 $362,695 $1,137,576 $712,560 $1,137,576 $11,000 $1,137,576
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1000694/000110465921060332/tm212692d3_def14a.htm

What are Novavax Inc's Past Insider Trades?

Novavax Inc's most recent insider trade came on April 4, 2022 by James Young who sold 12,500 units worth $919.76K . In the last 19 years, insiders at Novavax Inc have sold an estimated value of $286.8M and bought an estimated value of $38.15M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Gregory Glenn, President,  Gary Evans, Director,  and John A. Herrmann III, EVP .

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1